Perceptive Advisors as of June 30, 2020
Portfolio Holdings for Perceptive Advisors
Perceptive Advisors holds 124 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Amicus Therapeutics (FOLD) | 6.2 | $380M | 25M | 15.08 | |
| Global Blood Therapeutics In | 6.0 | $369M | 5.8M | 63.13 | |
| Retrophin Note 2.500% 9/1 (Principal) | 5.7 | $350M | 45M | 7.78 | |
| Iovance Biotherapeutics (IOVA) | 5.3 | $324M | 12M | 27.45 | |
| Mirati Therapeutics | 5.1 | $316M | 2.8M | 114.17 | |
| Neurocrine Biosciences (NBIX) | 4.2 | $261M | 2.1M | 122.00 | |
| Cytokinetics Note 4.000%11/1 (Principal) | 3.9 | $238M | 10M | 23.83 | |
| Bridgebio Pharma (BBIO) | 3.6 | $219M | 6.7M | 32.61 | |
| Kodiak Sciences (KOD) | 3.1 | $190M | 3.5M | 54.12 | |
| Vbi Vaccines Com New | 2.8 | $171M | 55M | 3.10 | |
| Collegium Pharmaceutical Note 2.625% 2/1 (Principal) | 2.6 | $157M | 18M | 8.98 | |
| Athenex | 2.5 | $156M | 12M | 13.52 | |
| Springworks Therapeutics (SWTX) | 2.4 | $148M | 3.5M | 42.00 | |
| Myokardia | 2.2 | $135M | 1.4M | 96.62 | |
| Zogenix Com New | 2.2 | $133M | 4.9M | 27.01 | |
| Zymeworks | 2.1 | $129M | 3.6M | 36.07 | |
| Nevro Corp Note 2.750% 4/0 (Principal) | 2.0 | $122M | 9.0M | 13.50 | |
| Nevro (NVRO) | 1.7 | $108M | 900k | 119.47 | |
| Quotient | 1.6 | $98M | 13M | 7.40 | |
| Meiragtx Holdings (MGTX) | 1.3 | $81M | 6.4M | 12.52 | |
| Kadmon Hldgs | 1.3 | $80M | 16M | 5.12 | |
| Frequency Therapeutics | 1.1 | $71M | 3.0M | 23.25 | |
| Arena Pharmaceuticals Com New | 1.1 | $69M | 1.1M | 62.95 | |
| Allogene Therapeutics (ALLO) | 1.1 | $66M | 1.5M | 42.82 | |
| Provention Bio | 1.0 | $64M | 4.5M | 14.11 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.0 | $59M | 3.7M | 16.17 | |
| Forma Therapeutics Hldgs SHS | 0.9 | $58M | 1.3M | 46.49 | |
| Vapotherm | 0.9 | $55M | 1.3M | 40.99 | |
| Blueprint Medicines (BPMC) | 0.9 | $54M | 689k | 78.00 | |
| Albireo Pharma | 0.8 | $52M | 2.0M | 26.49 | |
| Neptune Wellness Solutions I | 0.8 | $52M | 18M | 2.80 | |
| Adma Biologics (ADMA) | 0.8 | $49M | 17M | 2.93 | |
| Agios Pharmaceuticals (AGIO) | 0.8 | $48M | 900k | 53.48 | |
| Rocket Pharmaceuticals (RCKT) | 0.7 | $46M | 2.2M | 20.93 | |
| Zentalis Pharmaceuticals (ZNTL) | 0.7 | $46M | 1.1M | 43.60 | |
| Agile Therapeutics | 0.7 | $44M | 16M | 2.78 | |
| Black Diamond Therapeutics (BDTX) | 0.7 | $44M | 1.1M | 39.83 | |
| Menlo Therapeutics | 0.6 | $40M | 23M | 1.73 | |
| Verrica Pharmaceuticals | 0.6 | $38M | 3.4M | 11.01 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.6 | $36M | 2.1M | 17.50 | |
| Macrogenics (MGNX) | 0.6 | $36M | 1.3M | 27.92 | |
| Fusion Pharmaceuticals | 0.6 | $36M | 2.2M | 16.08 | |
| Molecular Templates | 0.6 | $34M | 2.5M | 13.79 | |
| Inari Medical Ord | 0.5 | $34M | 696k | 48.44 | |
| Dbv Technologies S A Sponsored Adr | 0.5 | $32M | 7.3M | 4.39 | |
| Avidity Biosciences Ord (RNA) | 0.5 | $32M | 1.2M | 25.58 | |
| Eidos Therapeutics | 0.5 | $30M | 687k | 43.84 | |
| Geron Corporation (GERN) | 0.5 | $29M | 14M | 2.18 | |
| Novavax Com New (NVAX) | 0.5 | $29M | 350k | 83.35 | |
| Retrophin | 0.5 | $29M | 3.2M | 8.91 | |
| Vaxcyte (PCVX) | 0.4 | $27M | 850k | 31.61 | |
| Immunovant (IMVT) | 0.4 | $27M | 1.1M | 24.35 | |
| AtriCure (ATRC) | 0.4 | $24M | 529k | 44.95 | |
| Urovant Sciences | 0.4 | $23M | 2.4M | 9.84 | |
| Adaptive Biotechnologies Cor (ADPT) | 0.4 | $23M | 480k | 48.38 | |
| Lyra Therapeutics | 0.4 | $22M | 1.9M | 11.34 | |
| Cytomx Therapeutics (CTMX) | 0.3 | $22M | 2.6M | 8.33 | |
| Concert Pharmaceuticals I equity | 0.3 | $21M | 2.2M | 9.95 | |
| Turning Point Therapeutics I | 0.3 | $21M | 330k | 64.59 | |
| Denali Therapeutics | 0.3 | $21M | 850k | 24.18 | |
| Dicerna Pharmaceuticals | 0.3 | $20M | 800k | 25.40 | |
| Solid Biosciences | 0.3 | $20M | 6.7M | 2.93 | |
| Iveric Bio | 0.3 | $18M | 3.5M | 5.10 | |
| Morphic Hldg (MORF) | 0.3 | $18M | 650k | 27.05 | |
| Leap Therapeutics | 0.3 | $18M | 8.5M | 2.06 | |
| Immunomedics | 0.3 | $16M | 462k | 35.44 | |
| Mylan Shs Euro | 0.3 | $16M | 1.0M | 16.08 | |
| Silk Road Medical Inc Common | 0.3 | $16M | 385k | 41.89 | |
| Stoke Therapeutics (STOK) | 0.3 | $16M | 672k | 23.83 | |
| Fulcrum Therapeutics (FULC) | 0.3 | $16M | 894k | 17.64 | |
| Y Mabs Therapeutics | 0.2 | $15M | 355k | 43.20 | |
| Establishment Labs Holdings SHS (ESTA) | 0.2 | $14M | 736k | 18.68 | |
| Hologic (HOLX) | 0.2 | $13M | 230k | 57.00 | |
| Aldeyra Therapeutics (ALDX) | 0.2 | $13M | 3.1M | 4.17 | |
| Alector (ALEC) | 0.2 | $13M | 512k | 24.44 | |
| Twist Bioscience Corp (TWST) | 0.2 | $12M | 273k | 45.30 | |
| Bellus Health Com New | 0.2 | $12M | 1.1M | 10.29 | |
| Revolution Medicines (RVMD) | 0.2 | $11M | 350k | 31.57 | |
| Insulet Corporation (PODD) | 0.2 | $10M | 53k | 194.26 | |
| Sc Health Corp Unit 99/99/9999 | 0.2 | $10M | 1.0M | 10.11 | |
| Health Catalyst (HCAT) | 0.2 | $9.8M | 336k | 29.17 | |
| Coherus Biosciences (CHRS) | 0.2 | $9.7M | 545k | 17.86 | |
| Regeneron Pharmaceuticals (REGN) | 0.2 | $9.4M | 15k | 623.60 | |
| Neoleukin Therapeutics | 0.1 | $8.9M | 537k | 16.60 | |
| Aquestive Therapeutics (AQST) | 0.1 | $8.5M | 1.8M | 4.86 | |
| 1life Healthcare | 0.1 | $7.9M | 219k | 36.32 | |
| Longview Acquisition Corp Unit 99/99/9999 | 0.1 | $7.1M | 700k | 10.10 | |
| Bio Rad Labs Cl A (BIO) | 0.1 | $7.0M | 16k | 451.48 | |
| Amyris Com New | 0.1 | $6.4M | 1.8M | 3.50 | |
| Dermtech Ord ord (DMTKQ) | 0.1 | $6.4M | 487k | 13.23 | |
| Moderna Put Option (MRNA) | 0.1 | $6.4M | 100k | 64.21 | |
| Vocera Communications | 0.1 | $6.1M | 290k | 21.20 | |
| Translate Bio | 0.1 | $5.6M | 315k | 17.92 | |
| Motus Gi Hldgs Incorporated | 0.1 | $5.6M | 4.2M | 1.32 | |
| Female Health (VERU) | 0.1 | $5.5M | 1.7M | 3.34 | |
| Viewray (VRAYQ) | 0.1 | $5.5M | 2.5M | 2.24 | |
| Axsome Therapeutics (AXSM) | 0.1 | $4.1M | 50k | 82.28 | |
| Burning Rock Biotech Sponsored Ads | 0.1 | $4.1M | 150k | 27.01 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 0.1 | $4.0M | 400k | 10.01 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 0.1 | $3.3M | 300k | 11.00 | |
| Alphatec Hldgs Com New (ATEC) | 0.0 | $2.6M | 562k | 4.70 | |
| Galera Therapeutics (GRTX) | 0.0 | $2.3M | 325k | 7.14 | |
| Phreesia (PHR) | 0.0 | $2.0M | 70k | 28.27 | |
| Medtronic SHS (MDT) | 0.0 | $1.8M | 20k | 91.70 | |
| Revance Therapeutics | 0.0 | $1.6M | 66k | 24.42 | |
| Dynavax Technologies Corp Com New (DVAX) | 0.0 | $1.6M | 177k | 8.87 | |
| Eiger Biopharmaceuticals | 0.0 | $1.3M | 140k | 9.60 | |
| Legend Biotech Corp Sponsored Ads (LEGN) | 0.0 | $1.1M | 25k | 42.56 | |
| Ferrari SHS (RACE) | 0.0 | $1.1M | 6.2k | 170.97 | |
| Livongo Health | 0.0 | $1.0M | 14k | 75.18 | |
| Momenta Pharmaceuticals | 0.0 | $1.0M | 31k | 33.26 | |
| Trillium Therapeutics Com New | 0.0 | $928k | 115k | 8.09 | |
| Sierra Oncology Com New | 0.0 | $807k | 67k | 12.11 | |
| Karuna Therapeutics Ord | 0.0 | $774k | 6.9k | 111.46 | |
| Akebia Therapeutics (AKBA) | 0.0 | $716k | 53k | 13.58 | |
| Repro-Med Systems (KRMD) | 0.0 | $672k | 75k | 8.98 | |
| Cue Biopharma (CUE) | 0.0 | $646k | 26k | 24.50 | |
| Luminex Corporation | 0.0 | $616k | 19k | 32.55 | |
| Chemocentryx | 0.0 | $590k | 10k | 57.55 | |
| Tg Therapeutics (TGTX) | 0.0 | $580k | 30k | 19.49 | |
| Vir Biotechnology (VIR) | 0.0 | $534k | 13k | 41.00 | |
| Apellis Pharmaceuticals (APLS) | 0.0 | $373k | 11k | 32.67 | |
| Avadel Pharmaceuticals Sponsored Adr | 0.0 | $133k | 8.7k | 15.32 | |
| Outlook Therapeutics *w Exp 02/18/202 | 0.0 | $108k | 421k | 0.26 |